Literature DB >> 11306456

CpG island methylation in premalignant stages of gastric carcinoma.

G H Kang1, Y H Shim, H Y Jung, W H Kim, J Y Ro, M G Rhyu.   

Abstract

There are limited reports on methylation analysis of the premalignant lesions of gastric carcinoma thus far. This is despite the fact that gastric carcinoma is one of the tumors with a high frequency of CpG island hypermethylation. To determine the frequency and timing of hypermethylation during multistep gastric carcinogenesis, non-neoplastic gastric mucosa (n = 118), adenomas (n = 61), and carcinomas (n = 64) were analyzed for their p16, human Mut L homologue 1 (hMLH1), death-associated protein (DAP)-kinase, thromobospondin-1 (THBS1), and tissue inhibitor of metalloproteinase 3 (TIMP-3) methylation status using methylation-specific PCR. Three different classes of methylation behaviors were found in the five tested genes. DAP-kinase was methylated at a similar frequency in all four stages, whereas hMLH1 and p16 were methylated in cancer samples (20.3% and 42.2%, respectively) more frequently than in intestinal metaplasia (6.3% and 2.1%, respectively) or adenomas (9.8% and 11.5%, respectively). However, hMLH1 and p16 were not methylated in chronic gastritis. THBS-1 and TIMP-3 were methylated in all stages but showed a marked increase in hypermethylation frequency from chronic gastritis (10.1% and 14.5%, respectively) to intestinal metaplasia (34.7% and 36.7%, respectively; P < 0.05) and from adenomas (28.3% and 26.7%, respectively) to carcinomas (48.4% and 57.4%, respectively: P < 0.05). The hMLH1, THBS1, and TIMP-3 hypermethylation frequencies were similar in both intestinal metaplasia and adenomas, but the p16 hypermethylation frequency tended to be higher in adenomas (11.5%) than in intestinal metaplasia (2.1%; P = 0.073). The average number of methylated genes was 0.6, 1.1, 1.1, and 2.0 per five genes per sample in chronic gastritis, intestinal metaplasia, adenomas, and carcinomas, respectively. This shows a marked increase in methylated genes from non-metaplastic mucosa to intestinal metaplasia (P = 0.001) as well as from premalignant lesions to carcinomas (P = 0.002). These results suggest that CpG island hypermethylation occur early in multistep gastric carcinogenesis and tend to accumulate along the multistep carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11306456

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  87 in total

1.  Gene methylation in non-neoplastic mucosa of gastric cancer: age or Helicobacter pylori related?

Authors:  Annie On On Chan; Shiu Kum Lam; Benjamin Chun-Yu Wong; Yok-Lam Kwong; Asif Rashid
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

2.  MAD1 (mitotic arrest deficiency 1) is a candidate for a tumor suppressor gene in human stomach.

Authors:  Mitsuhiko Osaki; Toshiaki Inoue; Shigeyuki Yamaguchi; Aiko Inaba; Naruo Tokuyasu; Kuan-Teh Jeang; Mitsuo Oshimura; Hisao Ito
Journal:  Virchows Arch       Date:  2007-08-03       Impact factor: 4.064

3.  Early involvement of death-associated protein kinase promoter hypermethylation in the carcinogenesis of Barrett's esophageal adenocarcinoma and its association with clinical progression.

Authors:  Doerthe Kuester; Altaf A Dar; Christopher C Moskaluk; Sabine Krueger; Frank Meyer; Roland Hartig; Manfred Stolte; Peter Malfertheiner; Hans Lippert; Albert Roessner; Wael El-Rifai; Regine Schneider-Stock
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

4.  Role of RECK methylation in gastric cancer and its clinical significance.

Authors:  Yun-Yi Du; Dong-Qiu Dai; Zhi Yang
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

Review 5.  How to stomach an epigenetic insult: the gastric cancer epigenome.

Authors:  Nisha Padmanabhan; Toshikazu Ushijima; Patrick Tan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-17       Impact factor: 46.802

6.  Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia.

Authors:  Takayoshi Waki; Gen Tamura; Takashi Tsuchiya; Kiyoshi Sato; Satoshi Nishizuka; Teiichi Motoyama
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  Helicobacter pylori and EBV in gastric carcinomas: methylation status and microsatellite instability.

Authors:  Adriana Camargo Ferrasi; Nídia Alice Pinheiro; Silvia Helena Barem Rabenhorst; Otávia Luisa Caballero; Maria Aparecida Marchesan Rodrigues; Fabrício de Carvalho; Celso Vieira de Souza Leite; Marcia Valéria Pitombeira Ferreira; Marcos Aurélio Pessoa Barros; Maria Inês Moura Campos Pardini
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

8.  Aberrant CpG island methylation of multiple genes in ependymal tumors.

Authors:  M Eva Alonso; M Josefa Bello; Pilar Gonzalez-Gomez; Dolores Arjona; Jose M de Campos; Manuel Gutierrez; Juan A Rey
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

9.  Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masakatsu Nakamura; Hiromi Yamashita; Daisuke Yoshioka; Masaaki Okubo; Naoko Maruyama; Toshiaki Kamano; Yoshio Kamiya; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Ichiro Hirata; Tomiyasu Arisawa
Journal:  Dig Dis Sci       Date:  2009-01-29       Impact factor: 3.199

10.  CpG island methylation profile of pancreatic intraepithelial neoplasia.

Authors:  Norihiro Sato; Noriyoshi Fukushima; Ralph H Hruban; Michael Goggins
Journal:  Mod Pathol       Date:  2007-12-21       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.